GFI1B作为造血与急性髓系白血病中的代谢调节因子
本文探讨转录因子GFI1B在造血和白血病发生中代谢重编程的作用。Gfi1b缺失显著激活线粒体呼吸,使能量代谢依赖转向氧化磷酸化(OXPHOS),线粒体底物依赖性由葡萄糖转向脂肪酸,并通过表观遗传调控多个脂肪酸氧化(FAO)相关基因。Gfi1b缺失的AML细胞对二甲双胍及OXPHOS和FAO抑制药物更敏感,提示潜在治疗策略。
要点
- Gfi1b缺失激活线粒体呼吸并使能量代谢依赖转向OXPHOS。
- Gfi1b缺失通过上调FAO使线粒体底物依赖性从葡萄糖转向脂肪酸。
- Gfi1b缺失的AML细胞对二甲双胍及OXPHOS和FAO抑制药物更敏感。
核心结论
- Gfi1b作为代谢调节因子,其缺失激活线粒体呼吸并改变能量代谢依赖,FAO或OXPHOS抑制可阻碍Gfi1b-KO MLL/AF9细胞的白血病进展。
- Gfi1b缺陷的AML细胞对二甲双胍及OXPHOS和FAO抑制药物更敏感,为潜在治疗策略。
研究设计与样本
- 基础研究,探讨Gfi1b在造血和白血病发生中代谢重编程的作用。
主要发现
- Gfi1b缺失显著激活线粒体呼吸,使能量代谢依赖转向OXPHOS。
- Gfi1b缺失通过上调FAO使线粒体底物依赖性从葡萄糖转向脂肪酸。
- Gfi1b在表观遗传层面调控多个FAO相关基因。
- 代谢表型随细胞从前白血病向白血病进展而演变,Gfi1b表达水平与代谢表型的相关性受AML细胞遗传变异影响。
- FAO或OXPHOS抑制显著阻碍Gfi1b-KO MLL/AF9细胞的白血病进展。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Recent studies highlighted the role of transcription factors in metabolic regulation during hematopoiesis and leukemia development. GFI1B is a transcriptional repressor that plays a critical role in hematopoiesis, and its expression is negatively related to the prognosis of acute myeloid leukemia (AML) patients. We earlier reported a change in the metabolic state of hematopoietic stem cells upon Gfi1b deletion. Here we explored the role of Gfi1b in metabolism reprogramming during hematopoiesis and leukemogenesis. We demonstrated that Gfi1b deletion remarkably activated mitochondrial respiration and altered energy metabolism dependence toward oxidative phosphorylation (OXPHOS). Mitochondrial substrate dependency was shifted from glucose to fatty acids upon Gfi1b deletion via upregulating fatty acid oxidation (FAO). On a molecular level, Gfi1b epigenetically regulated multiple FAO-related genes. Moreover, we observed that metabolic phenotypes evolved as cells progressed from preleukemia to leukemia, and the correlation between Gfi1b expression level and metabolic phenotype was affected by genetic variations in AML cells. FAO or OXPHOS inhibition significantly impeded leukemia progression of Gfi1b-KO MLL/AF9 cells. Finally, we showed that Gfi1b-deficient AML cells were more sensitive to metformin as well as drugs implicated in OXPHOS and FAO inhibition, opening new potential therapeutic strategies.
引用
- Liu L, Patnana PK, Xie X, et al. GFI1B acts as a metabolic regulator in hematopoiesis and acute myeloid leukemia. Leukemia. 2022. PMID: 35804097. doi:10.1038/s41375-022-01635-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。